INOXELL
DEAD

Serial Number

78090582

Owner

PHARMEXA A/S

Attorney

CYNTHIA CLARKE WEBER

Filing Date

Oct 29, 2001

Add to watchlist:

No watchlists yet
View on USPTO

INOXELL Trademark

Serial Number: 78090582

INOXELL is a trademark filed by PHARMEXA A/S on October 29, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PHARMEXA A/S (6 trademarks)

KOGLE ALLE 6
DK-2970 HORSHOLM , DK

Entity Type: 16

Trademark Details

Filing Date

October 29, 2001

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders; infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; chemical preparations, namely, biochemical preparations for laboratory analyses, for diagnostic and therapeutic use and for in vivo analyses in medical science research; biochemicals, namely, proteins, polypeptides, peptides and nucleic acids, all of the aforesaid goods for medical, diagnostic, therapeutic or veterinary purposes; molecular biological vectors, including retrovirus, adenovirus, and vaccinia virus vectors, all of the aforesaid goods for medical, diagnostic, therapeutic or veterinary purposes; biological and biochemical libraries, used as medical, diagnostic, therapeutic or veterinary reagents, including DNA and peptide libraries, the aforesaid goods for medical, diagnostic, therapeutic and veterinary use; recombinant cell lines, including packaging cells for use in preparation of retrovirus used as reagents for medical and veterinary purposes

Chemical products, including biochemical products, namely, proteins, peptides, polypeptides, nucleic acids, and molecular biological vectors for scientific, diagnostic, therapeutic and research laboratory use; chemical preparations, namely, biochemical preparations for laboratory analyses, for diagnostic and therapeutic use and for in vivo analyses in life science research; biochemicals and biomedicals, namely, proteins, polypeptides, peptides, nucleic acids, molecular biological vectors, including retrovirus, adenovirus and vaccinia virus vectors all for scientific, research laboratory, diagnostic and therapeutic use; biological and biochemical libraries used as scientific, therapeutic, diagnostic and research laboratory reagents, including DNA and peptide libraries; recombinant cell lines, including packaging cells for use in preparation of retrovirus used as reagents for scientific and research purposes; chemical products for use in the development of pharmaceuticals, drug targets, and drug leads for medical science

Scientific, industrial, biotechnological and biomedical research; development and identification of pharmaceutical preparations drug leads; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vivo and in vitro preclinical testing of drug leads; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research

Filing History

ABANDONMENT - EXPRESS MAILED
Oct 25, 2002 ABN1
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2002 CRFA
PAPER RECEIVED
Sep 17, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2002 CRFA
NON-FINAL ACTION MAILED
May 1, 2002 CNRT
NON-FINAL ACTION MAILED
Mar 18, 2002 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2002 CRFA
NON-FINAL ACTION MAILED
Jan 29, 2002 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2002 DOCK